Researchers from Tel Aviv University (TAU) and Sheba Medical Center have developed replacement skin for grafting in burn victims. Bioengineered from the patient’s own cells, it is stable, robust, and flexible and can achieve wound closure in half the time … Continue reading →

Israel’s PolyPid (see here previously) reported positive Phase III trial results on its delayed-release antibiotic treatment applied at the site of surgical infections. The reduction in the risk of infection after surgery was 58% in the 800-patient trial. https://en.globes.co.il/en/article-polypid-reports-positive-phase-3-surgical-infection-drug-trial-1001512420

Prof Liat Ayalon, of Israel’s Bar-Ilan University, is one of the United Nations’ Healthy Ageing 50: leaders transforming the world to be a better place to grow older. She has just been awarded a 2.5 million Euro grant from the … Continue reading →

A third of 97 “terminal” myeloma patients are still alive after five years thanks to Car-T cancer treatment, originally invented by Israeli scientists. These were the findings of an international study, including Israel’s Sourasky (Ichilov) Medical Center. https://www.ynetnews.com/health_science/article/s1wwwo11xgl

Israel’s MeMed (see here previously) reached a major milestone of more than 100,000 patients tested with its MeMed BV, the company’s flagship technology that accurately distinguishes between bacterial and viral infections in just 15 minutes. https://www.ourcrowd.com/startup-news/memed-bv-surpasses-100000-patient-tests-underscoring-adoption-of-rapid-host-response-diagnostics